These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20707732)

  • 1. Evolution of mitochondrial DNA content after planned interruption of HAART in HIV-infected pediatric patients.
    Noguera A; Morén C; Rovira N; Sànchez E; Garrabou G; Nicolàs M; Muñoz-Almagro C; Cardellach F; Miró O; Fortuny C
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):1015-8. PubMed ID: 20707732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART.
    Morén C; Noguera-Julian A; Rovira N; Garrabou G; Nicolàs M; Cardellach F; Martínez E; Sánchez E; Miró O; Fortuny C
    Antivir Ther; 2011; 16(5):719-24. PubMed ID: 21817193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study.
    Mussini C; Pinti M; Bugarini R; Borghi V; Nasi M; Nemes E; Troiano L; Guaraldi G; Bedini A; Sabin C; Esposito R; Cossarizza A
    AIDS; 2005 Oct; 19(15):1627-33. PubMed ID: 16184032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
    Legrand FA; Abadi J; Jordan KA; Davenport MP; Deeks SG; Fennelly GJ; Wiznia AA; Nixon DF; Rosenberg MG
    AIDS; 2005 Oct; 19(15):1575-85. PubMed ID: 16184026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children.
    Fortuny C; Noguera-Julian A; Alsina L; Bellido R; Sánchez E; Muñoz-Almagro C; Ruiz L; Jiménez R
    Pediatr Infect Dis J; 2011 May; 30(5):435-8. PubMed ID: 21030884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection.
    Monpoux F; Tricoire J; Lalande M; Reliquet V; Bebin B; Thuret I
    AIDS; 2004 Dec; 18(18):2401-9. PubMed ID: 15622316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
    López S; Coll O; Durban M; Hernàndez S; Vidal R; Suy A; Morén C; Casademont J; Cardellach F; Mataró D; Miró O; Garrabou G
    Antivir Ther; 2008; 13(6):833-8. PubMed ID: 18839784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.
    Rouet F; Fassinou P; Inwoley A; Anaky MF; Kouakoussui A; Rouzioux C; Blanche S; Msellati P;
    AIDS; 2006 Nov; 20(18):2315-9. PubMed ID: 17117017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
    HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.
    Banas B; Kost BP; Goebel FD
    Eur J Med Res; 2004 Aug; 9(8):371-7. PubMed ID: 15337626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
    Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
    Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.
    Morén C; Noguera-Julian A; Garrabou G; Catalán M; Rovira N; Tobías E; Cardellach F; Miró Ò; Fortuny C
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):111-6. PubMed ID: 22362155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
    Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Chan JW; Harrigan PR; O'Shaughnessy MV
    J Acquir Immune Defic Syndr; 2003 Sep; 34 Suppl 1():S85-90. PubMed ID: 14562863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.
    Miró O; Garrabou G; López S; Deig E; Vidal I; Infante AB; Cardellach F; Casademont J; Pedrol E
    Antivir Ther; 2006; 11(5):625-30. PubMed ID: 16964831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.